Clinical trial
A Study on the Efficacy and Safety of DIGNICAP™ System for Preventing Chemotherapy Induced Alopecia
NCT03712696 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study on the Efficacy and Safety of DIGNICAP™ System for Preventing Chemotherapy Induced Alopecia
- Lead sponsor
- European Institute of Oncology
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 18, 2014
- Completion date
- September 20, 2018
- Enrollment
- 139 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, chemotherapy-induced alopecia